"Medicare Expands Coverage to Include Weight Loss Drug Wegovy for Seniors"

Medicare will now cover certain weight loss drugs if they are approved for an additional health benefit, opening the door for broader coverage of popular medications like Novo Nordisk's Wegovy, which is now approved for heart health. This move comes as demand for weight loss treatments has surged despite limited insurance coverage. The new guidance allows Medicare Part D plans to cover obesity treatments with FDA approval for an added health benefit, potentially including future coverage for other weight loss medications being studied for conditions like fatty liver disease and sleep apnea.